2. Introduction
⢠Following information
about medication
therapy must be
thoroughly understood
â Effects of a drug
⢠Action
â Proper dosing
⢠Adult
⢠Pediatric
⢠Modification based on
history
â Indications
â Contraindications
â Administration
techniques
⢠Proper route
⢠Proper rate
â Side effects/adverse
effects
â Incompatibility with
other medications
â Precautions
â Antidotes
3. Introduction
⢠Study of pharmacology
â Extensive
⢠Encompasses complete study of drugs and how they
effect the body
â Includes
⢠Knowledge of history, source, physical and chemical
properties
⢠Drug compounding
⢠Mechanism of action, absorption, distribution,
biotransformation, and excretion (pharmacokinetics)
⢠Biochemical and physiological effects
(pharmacodynamics)
4. Drugs are chemicals used to
diagnose, treat, and prevent
disease.
Medication: any drug used for
therapeutic purposes
Definition
6. FOUR GOALS OF
PHARMACOLOGY
⢠Gain knowledge of
various drug types
⢠Describe forms in which
medications are
administered
⢠Describe proper modes
of administration
⢠Recognize toxicity and
overdose
7. Historical Trends in
Pharmacology
⢠Ancient health care
â Use of herbs and minerals
to treat the sick and injured
has been documented as
long ago as 2000B.C.
â Ancient Egyptians, Arabs,
and Greeks passed
formulations down through
generations
â 17th and 18th centuries
⢠Tinctures of opium,
coca, and digitalis were
available
⢠1796 Edward Jennerâs
smallpox inoculation
8. Historical Trends in
Pharmacology
⢠19th century
â Atropine, chloroform,
codeine, ether, and morphine
were in use
⢠20th century
â Animal insulin and penicillin
dramatically changed the
treatment of endocrine and
infectious diseases
⢠The present
â DNA technology
⢠Human insulin
⢠tPA
â Many medications previously
available only by prescription
are now sold over-the-counter
9. Major Sources of Drugs
⢠Natural: prototype drug,
model for synthetic
preparation
⢠Derived from 6 sources
â Animals and humans
â Vegetable
â Mineral
â Microorganisms
â Synthetic (CTA)
⢠Chemotherapeutic
agents
⢠Made in a laboratory
10. Sources of Drug Information
⢠United States Pharmacopoeia (USP)
⢠Physicianâs Desk Reference (PDR)
⢠Hospital Formulary (HF)
⢠Drug inserts
⢠Monthly Prescribing Reference
⢠AMA Drug Evaluation
⢠EMS Field Guide
11. Components of a Drug Profile
⢠Name
⢠Classification
⢠Mechanism of
Action
⢠Indications
⢠Pharmacokinetics
⢠Side Effects/adverse
reactions
⢠Routes of
Administration
⢠Contraindications
⢠Dosage
⢠How Supplied
⢠Special
Considerations
12. DRUG NAMES
⢠Official name
â Name listed in the United States
Pharmacopoeia (USP)
â Name listed in National Formulary (NF)
â Generic name when drug is approved for
use
⢠Chemical name
â Most elemental
â Precise description of drugâs chemical
composition and molecular structure
13. DRUG NAMES
⢠Generic name
â Often an abbreviated version of chemical name
â Name given to drug by first
manufacturer/before drug has become official
â Generic medications usually have same
therapeutic efficacy as nongeneric and are
less expensive
⢠Trade or proprietary name
â Name given a drug by manufacturer
⢠May have several trade names (multiple
manufacturers)
20. Routes of Administration
⢠How the drug is
administered
â Examples
⢠IV
⢠Endotracheal
⢠Rectal
⢠IM
⢠SQ
⢠Oral
21. Routes of Drug Administration
⢠Inhalation
â Nebulized medications
⢠Enteral (drugs
administered along any
portion of the
gastrointestinal tract)
â Sublingual
â Buccal
â Oral
â Rectal
â Nasogastric
22. ENTERAL ROUTE
⢠Drugs administered
along any portion of
the GI tract
⢠Safest, most
convenient and
economical route
⢠Least reliable and
slowest route due to
frequent changes in
GI environment
â Food contents
â Emotional state
â Physical activity
23. Routes of Drug
Administration
⢠Parenteral (any medication route other
than the alimentary canal)
â Subcutaneous
â Intramuscular
â Intravenous
â Intrathecal
â Pulmonary
â Intralingual
â Intradermal
â Transdermal
â Umbilical
â Intraosseous
â Nasal
â Endotracheal
24. PARENTERAL ROUTE (INJECTION)
⢠Subcutaneous
administration
â Injection given beneath skin
into the connective tissue or
fatty layer immediately
beneath the dermis
â Used only for small volumes
of drugs (0.5ml or less) that
do not irritate tissue
â Absorption rate is usually
slow and can provide a
sustained effect
â Common administration
sites:
⢠Upper outer arm
⢠Anterior thigh
⢠Abdomen
25. PARENTERAL ROUTES
⢠Intramuscular
administration
â Injection given into the
skeletal muscle
â Absorption generally
occurs more rapidly than
SQ injection because of
greater tissue blood flow
⢠Administered only to
patients with adequate
perfusion
â Usually involve volumes of
1-3ml
â Common administration
sites:
⢠Deltoid muscle
â Upper outer quadrant
of gluteus muscle
26. PARENTERAL ROUTES
⢠Intravenous administration
â Injection given directly into
bloodstream, bypassing
absorption process
â Provides an almost
immediate pharmacological
effect
â Blood levels more
predictable
â Most emergency
pharmacology administered
intravenously
â IV push vs IV bolus
27. PARENTERAL ROUTES
⢠Endotracheal administration
(transtracheal)
â Administration through an
established endotracheal tube
â Permits drug delivery into
pulmonary capillaries and
systemic absorption via lung
capillaries
â Absorption rate almost as rapid
as IV administration due to large
surface area of alveolar sacs
â Usually reserved for situations in
which an IV line cannot be
established
â ET medications: Lidocaine,
Epinephrine, Atropine, Naloxone
â ET drug dose: 2-2.5 times
intravenous dose diluted in 10cc
of NS
28. PARENTERAL ROUTES
⢠Intraosseous
administration
â Injection given directly into
bone marrow cavity
â Agents are thought to
circulate via medullary cavity
of bone
⢠Fluids and/or drugs
rapidly enter central
circulation through
numerous venous
channels of long bones
â Time from injection to entry
into systemic circulation is
thought to equal that of
venous administration
â Method of second choice
following IV
29. PULMONARY ROUTE
⢠Medication administration by
inhalation in the form of gas or
fine mist (aerosol)
⢠Bronchodilators are most
common inhalation
medications
⢠Absorption in bloodstream is
rapid due to large surface area
and rich capillary network
adjacent to alveolar membrane
⢠Primarily local effects/little
systemic absorption
â rapid onset
â smaller doses required
â individual dosage titration
available
31. Contraindications
⢠Conditions that make it inappropriate
to give the drug.
⢠âŚmeans a predictable harmful event
will occur if the drug is given in this
situation.
32. Dosage
⢠The amount of the
drug that should be
given.
â Concentration
â Volume
33. How Supplied
⢠This typically
includes the
common
concentration of
the available
preparations; many
drugs come in
different
concentrations.
34. Drug Forms
⢠Solid Forms:
â Such as pills, powders, suppositories,
capsules.
⢠Liquid Forms:
â Such as solutions, tinctures, suspensions,
emulsions, spirits, elixirs, syrups.
35. Solid Forms
⢠Pillsâdrugs shaped spherically to be
swallowed.
⢠Powdersânot as popular as they once were.
⢠Tabletsâpowders compressed into disk-like
form.
⢠Suppositoriesâdrugs mixed with a waxlike
base that melts at body temperature.
⢠Capsulesâgelatin containers filled with
powders or tiny pills.
36. Liquid Forms (1 of 2)
⢠Solutionsâwater or oil-based.
⢠Tincturesâprepared using an alcohol
extraction process.
⢠Suspensionsâpreparations in which
the solid does not dissolve in the
solvent.
⢠Emulsionsâsuspensions with an oily
substance in the solvent.
37. Liquid Forms (2 of 2)
⢠Spiritsâsolution of a volatile drug in
alcohol.
⢠Elixirsâalcohol and water solvent;
often with flavoring.
⢠Syrupsâsugar, water, and drug
solutions.
38. Mechanisms of Drug Actions
⢠Concentration of the drug at its site of action is
influenced by various processes, which are divided
into three phases of drug activity
â Pharmaceutical
⢠Disintegration of dosage form
⢠Dissolution of drug
â Pharmacokinetic
⢠Absorption, distribution, metabolism, excretion
â Pharmacodynamic
⢠Drug-receptor interaction
39. Pharmacokinetics
⢠Definition
â Study of the basic processes that
determine the duration and intensity of a
drugâs effect
â How drugs enter the body, reach their site
of action, and how they are eliminated
â Includes: Absorption, distribution,
metabolism, and elimination
40. Pharmacokinetics
⢠Physiology of transport
â Pharmacokinetics is dependent upon the bodyâs
physiological mechanisms that move substances across the
bodyâs compartments
⢠Active transport
â Requires the use of energy to move substances
â ATP is broken down into ADP liberating a
considerable amount of biochemical energy
â Example: Na - K pump
⢠Facilitated diffusion
â Process in which carrier proteins transport large
molecules across the cell membrane
â Example: Insulin - glucose relationship
41. Pharmacokinetics
⢠Physiology of transport
â Passive transport
⢠Movement of a substance without the use of
energy
⢠Requires the presence of concentration gradients
⢠Most drugs travel through the body by means of
passive transport
42. Pharmacokinetics
⢠Types of passive transport
â Diffusion
⢠Movement of solute in a solution from an area of
higher concentration to an area of lower concentration
â Osmosis
⢠Movement of solvent in a solution from an area of
lower solute concentration to an area of higher solute
concentration
â Filtration
⢠Movement of molecules across a membrane from an
area of higher pressure to an area of lower pressure
43. Pharmacokinetics
⢠Absorption
â Process involved in transferring drug molecules from the
place where they are deposited in the body to the circulating
fluids
â Drugs enter bloodstream and are transported to their sites of
action
â Examples
⢠Direct injection into bloodstream
⢠Injection into a muscle
⢠Injection into the subcutaneous tissue
⢠Oral administration
⢠Rectal administration
⢠Respiratory administration
44. Pharmacokinetics
⢠Absorption
â Variables that affect drug absorption
⢠Nature of absorbing surface
⢠Blood flow to the site of administration
⢠Solubility of the drug
⢠pH
⢠Drug concentration
⢠Dosage form
⢠Routes of drug administration
⢠Bioavailability
45. Pharmacokinetics
⢠Distribution
â Transport of a drug
through the bloodstream
to various tissues of the
body and ultimately to its
site of action
â Drug reservoirs
â Plasma protein binding
⢠Albumin
â Tissue binding
46. Pharmacokinetics
⢠Distribution
â Barriers to drug
distribution
⢠Some organs exclude
drugs from distribution
⢠Blood brain barrier
â Tight junction of
capillary endothelial
cells in the central
nervous system
vasculature through
which only non-protein
bound, highly lipid-
soluble drugs can pass
into CNS
⢠Placental barrier
â Biochemical barrier at
the maternal/fetal
interface that restricts
certain molecules
47. Pharmacokinetics
⢠Metabolism and Biotransformation
â Metabolism is the bodyâs breakdown of chemicals
to different chemicals
â Biotransformation is the special name given to the
metabolism of drugs
â Biotransformation has one of two effects
⢠Can transform a drug into a more or less active
metabolite
⢠Can make the drug more water soluble (or less
lipid soluble) to facilitate elimination
⢠Active and inactive metabolites
48. Pharmacokinetics
⢠Metabolism
â Majority occurs in liver (endoplasmic reticulum)
â Hepatic portal system
â First-pass effect
⢠Liverâs partial or complete inactivation of a drug
before it reaches the systemic circulation
â Drug microsomal metabolizing system
⢠Phase I: oxidation of drugs to make them more water
soluble to ease excretion
⢠Phase II: combines prodrug with endogenous
chemicals to make the drugs more polar and easier to
excrete
50. Pharmacodynamics
⢠Effect of a drug on the body (drug action)
⢠Types of drug actions
â Drug receptor interaction
â Changing the physical properties of cell
â Chemically combining with other chemicals
â Altering a normal metabolic pathway
51. Pharmacodynamics
⢠Drug receptor interaction
â Most drug actions are thought to
result from a chemical interaction
between drug and various
receptors throughout the body
â Receptor
⢠Protein complex on cell
membrane that combines
with a drug resulting in a
biological effect
⢠Analogy: Key and lock
mechanism
â Affinity
⢠Force of attraction between a
drug and a receptor
â Efficacy
⢠A drugâs ability to cause the
expected response
52. Pharmacodynamics
⢠Types of receptors
and locations (ANS)
â Beta 1:Heart
â Beta 2:Lungs
â Alpha 1:Vascular
â Alpha 2:Vascular
â Dopaminergic
⢠Renal, mesenteric,
and coronary vessels
53. Phamacodynamics
⢠Drug receptor interaction
â Second messenger
⢠Chemical that participates in complex cascading
reaction that eventually cause a drugâs desired
effect
â Down regulation
⢠Binding of a drug or hormone to a target cell
receptor that causes the number of receptors to
decrease
â Up regulation
⢠A drug causes the formation of more receptors than
normal
54. Pharmacodynamics
⢠Drug receptor interaction
â Agonist
⢠Drug that binds to a receptor and causes it to initiate the
desired response
â Antagonist
⢠Drug that binds to a receptor but does not cause it to
initiate the expected response
â Partial agonist (agonist-antagonist)
⢠Drug that binds to a receptor and stimulates some of its
effects, but blocks others
â Competitive antagonism
⢠One drug binds to a receptor and causes the expected
effect while blocking another drug from triggering the
same receptor
55. Pharmacodynamics
⢠Drugs that act by changing physical properties
â Changing physical properties of the body
⢠Example: osmotic diuretics change osmotic balance
increasing urine output
â Drugs that act by chemically combining with other
substances
⢠Example: denaturing of substances (antibiotics,
sodium bicarbonate)
â Drugs that act by altering a normal metabolic
pathway
⢠Example: anticancer and antiviral medications
56. Drug-Response Relationship
⢠To have optimal desired or therapeutic effects, a
drug must reach appropriate concentrations at its
site of action
⢠The magnitude of the response depends on
dosage and the drugâs course through the body
over time
⢠In the field, response to drug therapy is usually
assessed by observing the pharmacological
effect of the drug on easily measured
physiological parameters such as blood pressure
and pain relief
57. Drug-Response Relationship
⢠Plasma level profiles
â Describes the length of onset, duration, and termination of
action, as well as the drugâs minimum effective
concentration and toxic level
â Majority of information needed to describe drug response
relationships comes from plasma profiles
â Onset of action
⢠Time from administration until a medication reaches its
minimum effective concentration
â Minimum effective concentration
⢠Minimum level of drug needed to cause a given effect
58. Drug-Response
Relationship
⢠Plasma level profiles
â Duration of action
⢠Length of time that amount of drug remains above
its minimum effective concentration
â Termination of action
⢠Time from when the drugâs level drops below its
minimum effective concentration until it is
eliminated from the body
59. Drug-Response
Relationship
⢠Therapeutic index
â Ratio of a drugâs lethal dose for 50 percent of the
population to its effective dose for 50 percent of the
population
â Represents the drugâs margin of safety
⢠Biological half life
â Time body takes to clear one half of a drug
â Rate of biotransformation and excretion of a drug
determines it half life
60. Responses to Drug
Administration
⢠Predictable responses
â Desired action
â Side effects
⢠Iatrogenic responses
â Adverse effects produced unintentionally
⢠Unpredictable adverse responses
â Drug allergy (medications frequently implicated in allergic
reactions)
â Anaphylactic reaction
â Delayed reaction (serum sickness)
â Hypersensitivity
â Idiosyncracy
61. Responses to Drug Administration
⢠Side Effectâunintended response to a
drug.
⢠Allergic Reactionâhypersensitivity.
⢠Idiosyncrasyâdrug effect unique to
an individual.
62. Responses to Drug Administration
⢠Toleranceâdecreased response to
the same amount.
⢠Cross Toleranceâtolerance for a drug
that develops after administration of
a different drug.
⢠Tachyphylaxisârapidly occurring
tolerance to a drug.
63. Responses to Drug Administration
⢠Cumulative effectâincreased effectiveness
when a drug is given in several doses.
⢠Drug dependenceâthe patient becomes
accustomed to the drugâs presence in his
body.
⢠Drug interactionâthe effects of one drug
alter the response to another drug.
⢠Drug antagonismâthe effects of one drug
block the response to another drug.
64. Responses to Drug Administration
⢠Summationâalso known as additive
effect, two drugs with the same effect
are given together â similar to 1+1=2.
⢠Synergismâtwo drugs with the same
effect are given together and produce a
response greater than the sum of their
individual responses â similar to 1+2=3.
65. Responses to Drug Administration
⢠Potentiationâone drug enhances
the effect of another.
⢠Interferenceâthe direct biochemical
interaction between two drugs; one drug
affects the pharmacology of another drug.
66. Factors Altering Drug
Response
⢠Individuals may have different responses to the same drug
⢠Factors that alter standard drug-response relationship include
â Age
⢠Liver and kidney functions of infants are not fully developed
⢠Elderly liver and kidney functions decline
â Body mass
⢠The more body mass a person has, the more fluid is
available to dilute a drug
⢠Drug will cause a higher concentration in a person with little
versus large body mass
67. Factors Altering Drug Response
⢠Sex
â Most differences in drug reactions due to sex are based on body
mass and fluid composition
⢠Environmental milieu
â Various environmental stimuli affect drug response
⢠Stress
⢠Vasodilation
⢠Time of administration
â Before eating versus after eating
⢠Pathologic state
â Disease states alter the drug-response relationship
⢠Renal and hepatic dysfunction
⢠Acid base disturbances
⢠Genetic factors
⢠Psychological factors
68. Drug Interactions
⢠Variables influencing drug interaction
include
â Intestinal absorption
â Competition for plasma protein binding
â Drug metabolism or biotransformation
â Action at the receptor site
â Renal excretion
â Alteration of electrolyte balance
69. Drug Interactions
⢠Other drug interactions
â Drug induced malabsorption of food and
nutrients
â Food induced malabsorption of drugs
â Alteration of enzymes
â Alcohol consumption
â Cigarette smoking
â Food-initiated alteration of drug excretion
70. Drug Storage
⢠Certain precepts should
guide the manner in which
drugs are secured, stored,
distributed, and accounted
for
⢠Drug potency can be
affected by
â Temperature
â Light
â Moisture
â Shelf life
â Applies also to diluents
⢠Security of controlled
medications